feed,title,long_url,short_url
Benzinga,Argenx Regains Global Rights from Johnson & Johnson to Blood Cancer Candidate Cusatuzumab,https://benzinga.com/general/biotech/21/06/21446272/argenx-regains-global-rights-from-johnson-johnson-to-blood-cancer-candidate-cusatuzumab,https://j.mp/3geNvxH
